Masimo, a medical technology company based out of California, has been embroiled in a legal battle with Apple that led to a temporary cessation of Apple Watch sales in the US. Recently, Joe Kiani, the Masimo CEO, has spoken to the Wall Street Journal about being one of the few CEOs willing to take on Apple.
Just last month, it was revealed that the Apple Watch Series 9 and Ultra 2 would be pulled off sale in the US as Masimo claims Apple has infringed on its Blood Oxygen monitoring patents, with sales officially stopping just days later. The import ban was then lifted until a motion for a longer pause could be seen. This could mean that next year’s Apple Watch will need a workaround for the monitoring tech.
